Recommendations for Administration with Enteral Nutrition
DULoxetine (Cymbalta)
Capsule contains delayed release granules
Do NOT administer through feeding tube. Use therapeutic alternative.
2023 American Geriatrics Society Beers Criteria® for potentially inappropriate medication use in older adults.
Medication:
DULoxetine (Cymbalta)
Criteria 2: Potentially inappropriate medication use in older adults due to drug–disease or drug–syndrome interactions that may exacerbate the disease or syndrome. (Table 3)
Drug(s) ⇆ disease or syndrome
antidepressants (selected classes: SNRIs) ⇄ History of falls or fractures
Rationale
May cause ataxia, impaired psychomotor function, syncope, or additional falls. Antidepressants (selected classes): evidence for risk of falls and fractures is mixed; newer evidence suggests that SNRIs may increase falls risk. If one of the drugs must be used, consider reducing the use of other CNS-active medications that increase the risk of falls and fractures. (i.e., anticholinergics, selected antidepressants, antiepileptics, antipsychotics, sedative/hypnotics including benzodiazepines and, Nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids) and implement other strategies to reduce fall risk.
Recommendation
Avoid unless safer alternatives are not available.
Quality of evidence: Moderate, Strength of Recommendation: Strong
Criteria 3: Potentially inappropriate medications: drugs to be used with caution in older adults. (Table 4)
Drug(s)
antidepressants (selected: SNRIs)
Rationale
May exacerbate or cause SIADH or hyponatremia; monitor sodium levels closely when starting or changing dosages in older adults.
Recommendation
Use with caution
Quality of evidence: Moderate, Strength of Recommendation: Strong
Criteria 4: Potentially clinically important drug-drug interactions that should be avoided in older adults. (Table 5)
Interacting drug(s) or class(es)
antidepressants (TCAs, SSRIs, and SNRIs) ⇄ CNS-active agents
Risk Rationale
Increased risk of falls and of fracture with the concurrent use of ≥3 CNS-active agents (antiepileptics including gabapentinoids, antidepressants, antipsychotics, benzodiazepines, Nonbenzodiazepine benzodiazepine receptor agonist hypnotics, opioids, and skeletal muscle relaxants).
Recommendation
Avoid concurrent use of ≥3 CNS-active drugs Click for list; minimize the number of CNS-active drugs.
Quality of evidence: High, Strength of Recommendation: Strong
Criteria 5: medications that should be avoided or have their dosage reduced with varying levels of kidney function in older adults. (Table 6)
CrCl (mL/min) at which action is required
<30
Rationale
Increased GI adverse effects (nausea, diarrhea)
Recommendation
Avoid
Quality of evidence: Moderate, Strength of Recommendation: Weak
(Brand)
(Cymbalta)